Dr. Yasmine Belkaid of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is chief of the Mucosal Immunology section and co-director of the trans-NIH metaorganisms initiative. Her work explores mechanisms at barrier sites (i.e.
Dr. Mimi Tang, on treating peanut allergy with oral immunotherapy and a bacterial adjuvant
2 Mar 2015by Kristina Campbell
Dr. Mimi L. K. Tang is a paediatric allergist immunologist and director of the Department of Allergy and Immunology at the Royal Children's Hospital Melbourne.
Deletion of MyD88 in intestinal epithelial cells partially protects against diet-induced obesity
26 Feb 2015by Patrice D. Cani
In this paper, the first aim we had with Dr. Amandine Everard, was to investigate whether some key molecules involved in the innate immune system, mainly MyD88 [myeloid differentiation primary response gene 88], may contribute to the development of obesity, diabetes and low grade inflammation.
Genes contribute to the risk of celiac disease (CD), but the role of environmental factors, including perturbations in gut microbiota, is so far unclear.
Neha Alang and Colleen R. Kelly recently reported that a patient who had received fecal microbiota transplantation (FMT) developed obesity (1).
Dr. Faming Zhang, on treating refractory Crohn’s disease with fecal microbiota transplantation
12 Jan 2015by Kristina Campbell
Dr. Faming Zhang, MD, PhD, is a doctor and researcher at the Institute for Digestive Endoscopy & Medical Center for Digestive Diseases at The Second Affiliated Hospital of Nanjing Medical University in Nanjing, China. He is Vice Chief of the Medical Center for Digestive Diseases, and Director of Intestinal Diseases.
Why do some children suffer adverse vaccine events while others escape injury? What can be done to limit risk of injury by vaccination? Current CDC (Centers for Disease Control and Prevention) vaccine protocol beginning within 12 hours of birth does not factor gut microbiota as crucial to immune response.
The Inflammatory Bowel Diseases (IBDs), which include Crohn's Disease (CD) and Ulcerative Colitis (UC) are chronic relapsing and remitting inflammatory disorders of the gastrointestinal tract.
This article, published in Cell Host & Microbe, looked at human immunodeficiency virus, type 1 (HIV-1) Envelope gp41 antibodies. (Gp41 is a protein on the surface of HIV that helps the virus invade the host's cells; it is of interest to
I participated in the "Targeting microbiota" congress at Pasteur Institute because I considered the topics discussed very interesting and relevant to my research. For me microbiome conferences are still a rather foreign territory, but I very much like to talk
